Industry experts will be hosting an active discussion about how clinical trials with increased patient diversity lead to more successful treatments that make a real difference for the people who need them most.
Featuring panelists from Bristol Myers Squibb, ConcertAI, Emory-Winship Cancer Center and the Society for Clinical Research Sites (SCRS).
How are clinical trials with increased patient diversity leading to more successful treatments? While industry progress toward diverse clinical trials has been slow, we are seeing many inspiring cases that are using more inclusive patient populations to provide effective treatments for the communities that need them. How can early development of sound clinical and ethical expectations for a trial drive better outcomes? What difference does it make to apply business intelligence and analytics to the challenges of diversity? Join this discussion with industry experts to learn how a trial sponsor or CRO makes this work.